This study sought to functionalize RNVs with a diverse array of tumor-targeting ligands – cRGD, transferrin (TRF), folic acid (FA), GE11, and RVG29 – and to systematically compare their tumor-homing efficiency, biodistribution, and biosafety in a breast cancer model. Here, TF is linked to breast carcinoma.